1,030
Participants
Start Date
April 9, 2019
Primary Completion Date
February 28, 2022
Study Completion Date
July 31, 2022
DES-CRE8
Polymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption.
Centre Hospitalier Brive, Brive-la-Gaillarde
Hôpital Privé de Bourgogne, Dijon
Centre Hospitalier Valence, Valence
Centre Hospitalier Universitaire Grenoble, Grenoble
Clinique Saint-Joseph, Trélazé
Clinique Pasteur, Essey-lès-Nancy
Centre Hospitalier Vannes, Vannes
Centre Hospitalier Beauvais, Beauvais
Centre Hospitalier Pau, Pau
Centre Hospitalier Haguenau, Haguenau
Hôpital Schweitzer, Colmar
Centre Hospitalier Saint-Joseph Saint-Luc, Lyon
Clinique Saint-Hilaire, Rouen
Clinique de l'Europe, Amiens
Clinique Pont de Chaumes, Montauban
Centre Hospitalier Avignon, Avignon
Centre Hospitalier Sud-Francilien, Corbeil-Essonnes
Centre Hospitalier Gonesse, Gonesse
Hôpital Simone Veil, Eaubonne
Centre Hospitalier Chartres, Chartres
Clinique Convert, Bourg-en-Bresse
Centre Hospitalier Saint-Quentin, Saint-Quentin
Lead Sponsor
EVAMED
OTHER
Alvimedica Medical Technologies France
INDUSTRY